OneThree Biotech

Curated by Signal

Developer of AI-based drug discovery and development platform

Overview

Developer of AI-based drug discovery and development platform. The company platform use AI to mine through data to identify novel targets, compounds, and combination therapies. The company has developed drugs for ovarian cancer, solid tumors, and kidney cancer.

Key facts

Founded: 2018
Headquarters: New York City, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Aldera
Web-based health care claims adjudication platform
Health TechnologyLisle, United States
DNAVisit
Provider of AI-based genetic counselling for patients
Health TechnologySan Diego, United States
Medbee
Provider of smart courier service for medical laboratories and hospitals
Health TechnologySan Francisco, United States

About OneThree Biotech

What does OneThree Biotech do?

Developer of AI-based drug discovery and development platform.

Where is OneThree Biotech headquartered?

OneThree Biotech is headquartered in New York City, United States.

When was OneThree Biotech founded?

OneThree Biotech was founded in 2018.

Which sector is OneThree Biotech in?

OneThree Biotech operates in Health Technology.

Who are OneThree Biotech's competitors?

Companies similar to OneThree Biotech include Aldera, DNAVisit, and Medbee.